A business in context

MEDS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-04 · 8012 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-11 · 0001493152-26-043169 · Items 8.01

  2. 8-K · Current report

    Report date 2026-09-11 · 0001493152-26-042951 · Items 1.01,2.03,3.02,7.01,9.01

  3. 8-K · Current report

    Report date 2026-08-17 · 0001493152-26-038891 · Items 2.02,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-038581

  5. 8-K · Current report

    Report date 2026-08-14 · 0001493152-26-038475 · Items 8.01,9.01

  6. 8-K · Current report

    Report date 2026-07-29 · 0001493152-26-036005 · Items 1.01,9.01

  7. 8-K · Current report

    Report date 2026-07-27 · 0001493152-26-035058 · Items 8.01,9.01

  8. 8-K · Current report

    Report date 2026-07-20 · 0001493152-26-034086 · Items 5.03,8.01,9.01

  9. 4 · Ownership change

    Report date 2026-06-22 · 0001493152-26-030154

  10. 4 · Ownership change

    Report date 2026-06-22 · 0001493152-26-030151

  11. 4/A · Ownership change

    Report date 2026-03-31 · 0001493152-26-030123

  12. 4/A · Ownership change

    Report date 2026-03-31 · 0001493152-26-030122

  13. 8-K · Current report

    Report date 2026-06-09 · 0001493152-26-028464 · Items 3.01,8.01

  14. 8-K/A · Current report

    Report date 2026-05-27 · 0001493152-26-027063 · Items 9.01

  15. 8-K/A · Current report

    Report date 2026-05-27 · 0001493152-26-026879 · Items 9.01

  16. 8-K · Current report

    Report date 2026-05-27 · 0001493152-26-026452 · Items 1.01,3.02,7.01,9.01

  17. 8-K · Current report

    Report date 2026-05-21 · 0001493152-26-024823 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-05-19 · 0001493152-26-024723 · Items 1.01,2.03,3.02,3.03,5.02,5.03,9.01

  19. 8-K · Current report

    Report date 2026-05-19 · 0001493152-26-024454 · Items 2.02,7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-024413

  21. 8-K · Current report

    Report date 2026-05-15 · 0001493152-26-024324 · Items 7.01,9.01

  22. 8-K · Current report

    Report date 2026-05-18 · 0001493152-26-024058 · Items 8.01

  23. 8-K · Current report

    Report date 2026-05-01 · 0001493152-26-021718 · Items 1.01,9.01

  24. DEF 14A · Proxy statement

    Report date 2026-05-04 · 0001493152-26-021106

  25. 8-K/A · Current report

    Report date 2026-02-09 · 0001493152-26-021102 · Items 1.01

  26. 10-K/A · Annual report

    Report date 2025-12-31 · 0001493152-26-018958

  27. 4 · Ownership change

    Report date 2026-03-31 · 0001493152-26-018820

  28. 4 · Ownership change

    Report date 2026-03-31 · 0001493152-26-018817

  29. 8-K/A · Current report

    Report date 2026-04-17 · 0001493152-26-018326 · Items 1.01,3.01,3.02,7.01,9.01

  30. 8-K · Current report

    Report date 2026-04-17 · 0001493152-26-017895 · Items 1.01,3.02,7.01,9.01

  31. 8-K · Current report

    Report date 2026-04-03 · 0001493152-26-015898 · Items 1.01,8.01

  32. 8-K · Current report

    Report date 2026-04-01 · 0001493152-26-015548 · Items 1.01,2.03,3.02,9.01

  33. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-012004

  34. 8-K · Current report

    Report date 2026-03-06 · 0001493152-26-009702 · Items 1.01,7.01,9.01

  35. 8-K · Current report

    Report date 2026-03-09 · 0001493152-26-009384 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2026-02-04 · 0001493152-26-006815 · Items 1.01,3.02,7.01,8.01,9.01

  37. 8-K · Current report

    Report date 2026-02-04 · 0001493152-26-005819 · Items 5.02,7.01,9.01

  38. 8-K · Current report

    Report date 2026-02-01 · 0001493152-26-005387 · Items 5.02,9.01

  39. 4 · Ownership change

    Report date 2025-07-02 · 0001641172-25-018239

  40. 4 · Ownership change

    Report date 2025-03-21 · 0001641172-25-000603

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-30 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 8 transaction rows8AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-22
2026-06-25
AJJARAPU SURENDRA KX · Other (see filing)
Acquired
Common Stock100000.00.01
2026-06-22
2026-06-25
AJJARAPU SURENDRA KX · Other (see filing)
Acquired
Warrant
Derivative security
100000.00.0
2026-06-22
2026-06-25
Patel PrashantX · Other (see filing)
Acquired
Common Stock100000.00.01
2026-06-22
2026-06-25
Patel PrashantX · Other (see filing)
Acquired
Warrant
Derivative security
100000.00.0
2026-03-31
2026-06-25 · Amendment
AJJARAPU SURENDRA KA · Grant / award
Acquired
Common Stock5000000.00.2
2026-03-31
2026-06-25 · Amendment
AJJARAPU SURENDRA KA · Grant / award
Acquired
Warrant
Derivative security
5000000.00.0
2026-03-31
2026-06-25 · Amendment
Patel PrashantA · Grant / award
Acquired
Common Stock5000000.00.2
2026-03-31
2026-06-25 · Amendment
Patel PrashantA · Grant / award
Acquired
Warrant
Derivative security
5000000.00.0
2026-03-31
2026-04-23
Patel PrashantA · Grant / award
Acquired
Common Stock5000000.00.2
2026-03-31
2026-04-23
Patel PrashantA · Grant / award
Acquired
Warrant
Derivative security
5000000.00.01
2026-03-31
2026-04-23
AJJARAPU SURENDRA KA · Grant / award
Acquired
Common Stock5000000.00.2
2026-03-31
2026-04-23
AJJARAPU SURENDRA KA · Grant / award
Acquired
Warrant
Derivative security
5000000.00.01

Identity & relationships

Wikidata structured data · retrieved 2026-09-30 · 1613 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0002030763DataMeds AI, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-30 · 1178 checked identities; 0 unavailable records

Search names and former names
  • Wellgistics Health, Inc. · former SEC name · 2024-08-01 to 2026-07-21
  • Danam Health, Inc · former SEC name · 2024-07-22 to 2024-09-27

Revenue in constant purchasing power

USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$18.13M$19.36M

Bureau of Labor Statistics · retrieved 2026-10-04 · 9 selected series; gaps remain missing

Explore the CPI history ↗